Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TIV + MVA-NP+M1
- Development stage
- Unknown
- Lead developer
- Barinthus Biotherapeutics
- Modality
- Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
TIV + MVA-NP+M1 is a combination vaccine approach that pairs a traditional Trivalent Influenza Vaccine (TIV) with a novel viral vector vaccine (MVA-NP+M1). The MVA-NP+M1 component is a recombinant, replication-deficient Modified Vaccinia Ankara (MVA) vector expressing the influenza antigens nucleoprotein (NP) and matrix protein 1 (M1) as a fusion protein. This combination aims to provide broader protection against influenza by stimulating different immune responses simultaneously - TIV induces antibody responses against specific circulating strains, while MVA-NP+M1 stimulates T-cell responses against conserved internal influenza proteins that may offer cross-protection against different influenza strains.
02
Targets
HA (Hemagglutinin)NPM1 (Nucleophosmin)
Beyond the preview
Go deeper on TIV + MVA-NP+M1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TIV + MVA-NP+M1.